Effect of local medical opinion leaders on quality of care for acute myocardial infarction

Stephen B. Soumerai, Thomas J. McLaughlin, Jerry H. Gurwitz, Edward Guadagnoli, Paul Hauptman, Catherine Borbas, Nora Morris, Barbara McLaughlin, Xiaoming Gao, Donald J. Willison, Richard Asinger, Fredarick Gobel

Research output: Contribution to journalArticle

353 Citations (Scopus)

Abstract

Context.-The effectiveness of recruiting local medical opinion leaders to improve quality of care is poorly understood. Objective.-To evaluate a guideline-implementation intervention of clinician education by local opinion leaders and performance feedback to (1) increase use of lifesaving drugs (aspirin and thrombolytics in eligible elderly patients, β-blockers in all eligible patients) for acute myocardial infarction (AMI), and (2) decrease use of a potentially harmful therapy (prophylactic lidocaine). Design.- Randomized controlled trial with hospital as the unit of randomization, intervention, and analysis. Setting.-Thirty-seven community hospitals in Minnesota. Patients.-All patients with AMI admitted to study hospitals over 10 months before (1992-1993, N=2409) or after (1995-1996, N=2938) the intervention. Intervention.-Using a validated survey, we identified opinion leaders at 20 experimental hospitals who influenced peers through small and large group discussions, informal consultations, and revisions of protocols and clinical pathways. They focused on (1) evidence (drug efficacy), (2) comparative performance, and (3) barriers to change. Control hospitals received mailed performance feedback. Main Outcome Measures.-Hospital- specific changes before and after the intervention in the proportion of eligible patients receiving each study drug. Results.-Among experimental hospitals, the median change in the proportion of eligible elderly patients receiving aspirin was +0.13 (17% increase from 0.77 at baseline), compared with a change of -0.03 at control hospitals (P=.04). For β-blockers, the respective changes were +0.31 (63% increase from 0.49 at baseline) vs +0.18 (30% increase from baseline) for controls (P=.02). Lidocaine use declined by about 50% in both groups. The intervention did not increase thrombolysis in the elderly (from 0.73 at baseline), but nearly two thirds of eligible nonrecipients were older than 85 years, had severe comorbidities, or presented after at least 6 hours. Conclusions.-Working with opinion leaders and providing performance feedback can accelerate adoption of some beneficial AMI therapies (eg, aspirin, β-blockers). Secular changes in knowledge and hospital protocols may extinguish outdated practices (eg, prophylactic lidocaine). However, it is more difficult to increase use of effective but riskier treatments (eg, thrombolysis) for frail elderly patients.

Original languageEnglish (US)
Pages (from-to)1358-1363
Number of pages6
JournalJournal of the American Medical Association
Volume279
Issue number17
DOIs
StatePublished - May 6 1998

Fingerprint

Quality of Health Care
Myocardial Infarction
Lidocaine
Aspirin
Frail Elderly
Hospital Units
Critical Pathways
Fibrinolytic Agents
Community Hospital
Random Allocation
Pharmaceutical Preparations
Comorbidity
Therapeutics
Referral and Consultation
Randomized Controlled Trials
Outcome Assessment (Health Care)
Guidelines
Education

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Soumerai, S. B., McLaughlin, T. J., Gurwitz, J. H., Guadagnoli, E., Hauptman, P., Borbas, C., ... Gobel, F. (1998). Effect of local medical opinion leaders on quality of care for acute myocardial infarction. Journal of the American Medical Association, 279(17), 1358-1363. https://doi.org/10.1001/jama.279.17.1358

Effect of local medical opinion leaders on quality of care for acute myocardial infarction. / Soumerai, Stephen B.; McLaughlin, Thomas J.; Gurwitz, Jerry H.; Guadagnoli, Edward; Hauptman, Paul; Borbas, Catherine; Morris, Nora; McLaughlin, Barbara; Gao, Xiaoming; Willison, Donald J.; Asinger, Richard; Gobel, Fredarick.

In: Journal of the American Medical Association, Vol. 279, No. 17, 06.05.1998, p. 1358-1363.

Research output: Contribution to journalArticle

Soumerai, SB, McLaughlin, TJ, Gurwitz, JH, Guadagnoli, E, Hauptman, P, Borbas, C, Morris, N, McLaughlin, B, Gao, X, Willison, DJ, Asinger, R & Gobel, F 1998, 'Effect of local medical opinion leaders on quality of care for acute myocardial infarction', Journal of the American Medical Association, vol. 279, no. 17, pp. 1358-1363. https://doi.org/10.1001/jama.279.17.1358
Soumerai, Stephen B. ; McLaughlin, Thomas J. ; Gurwitz, Jerry H. ; Guadagnoli, Edward ; Hauptman, Paul ; Borbas, Catherine ; Morris, Nora ; McLaughlin, Barbara ; Gao, Xiaoming ; Willison, Donald J. ; Asinger, Richard ; Gobel, Fredarick. / Effect of local medical opinion leaders on quality of care for acute myocardial infarction. In: Journal of the American Medical Association. 1998 ; Vol. 279, No. 17. pp. 1358-1363.
@article{ad654028b47145c9a49e6111553b9f40,
title = "Effect of local medical opinion leaders on quality of care for acute myocardial infarction",
abstract = "Context.-The effectiveness of recruiting local medical opinion leaders to improve quality of care is poorly understood. Objective.-To evaluate a guideline-implementation intervention of clinician education by local opinion leaders and performance feedback to (1) increase use of lifesaving drugs (aspirin and thrombolytics in eligible elderly patients, β-blockers in all eligible patients) for acute myocardial infarction (AMI), and (2) decrease use of a potentially harmful therapy (prophylactic lidocaine). Design.- Randomized controlled trial with hospital as the unit of randomization, intervention, and analysis. Setting.-Thirty-seven community hospitals in Minnesota. Patients.-All patients with AMI admitted to study hospitals over 10 months before (1992-1993, N=2409) or after (1995-1996, N=2938) the intervention. Intervention.-Using a validated survey, we identified opinion leaders at 20 experimental hospitals who influenced peers through small and large group discussions, informal consultations, and revisions of protocols and clinical pathways. They focused on (1) evidence (drug efficacy), (2) comparative performance, and (3) barriers to change. Control hospitals received mailed performance feedback. Main Outcome Measures.-Hospital- specific changes before and after the intervention in the proportion of eligible patients receiving each study drug. Results.-Among experimental hospitals, the median change in the proportion of eligible elderly patients receiving aspirin was +0.13 (17{\%} increase from 0.77 at baseline), compared with a change of -0.03 at control hospitals (P=.04). For β-blockers, the respective changes were +0.31 (63{\%} increase from 0.49 at baseline) vs +0.18 (30{\%} increase from baseline) for controls (P=.02). Lidocaine use declined by about 50{\%} in both groups. The intervention did not increase thrombolysis in the elderly (from 0.73 at baseline), but nearly two thirds of eligible nonrecipients were older than 85 years, had severe comorbidities, or presented after at least 6 hours. Conclusions.-Working with opinion leaders and providing performance feedback can accelerate adoption of some beneficial AMI therapies (eg, aspirin, β-blockers). Secular changes in knowledge and hospital protocols may extinguish outdated practices (eg, prophylactic lidocaine). However, it is more difficult to increase use of effective but riskier treatments (eg, thrombolysis) for frail elderly patients.",
author = "Soumerai, {Stephen B.} and McLaughlin, {Thomas J.} and Gurwitz, {Jerry H.} and Edward Guadagnoli and Paul Hauptman and Catherine Borbas and Nora Morris and Barbara McLaughlin and Xiaoming Gao and Willison, {Donald J.} and Richard Asinger and Fredarick Gobel",
year = "1998",
month = "5",
day = "6",
doi = "10.1001/jama.279.17.1358",
language = "English (US)",
volume = "279",
pages = "1358--1363",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "17",

}

TY - JOUR

T1 - Effect of local medical opinion leaders on quality of care for acute myocardial infarction

AU - Soumerai, Stephen B.

AU - McLaughlin, Thomas J.

AU - Gurwitz, Jerry H.

AU - Guadagnoli, Edward

AU - Hauptman, Paul

AU - Borbas, Catherine

AU - Morris, Nora

AU - McLaughlin, Barbara

AU - Gao, Xiaoming

AU - Willison, Donald J.

AU - Asinger, Richard

AU - Gobel, Fredarick

PY - 1998/5/6

Y1 - 1998/5/6

N2 - Context.-The effectiveness of recruiting local medical opinion leaders to improve quality of care is poorly understood. Objective.-To evaluate a guideline-implementation intervention of clinician education by local opinion leaders and performance feedback to (1) increase use of lifesaving drugs (aspirin and thrombolytics in eligible elderly patients, β-blockers in all eligible patients) for acute myocardial infarction (AMI), and (2) decrease use of a potentially harmful therapy (prophylactic lidocaine). Design.- Randomized controlled trial with hospital as the unit of randomization, intervention, and analysis. Setting.-Thirty-seven community hospitals in Minnesota. Patients.-All patients with AMI admitted to study hospitals over 10 months before (1992-1993, N=2409) or after (1995-1996, N=2938) the intervention. Intervention.-Using a validated survey, we identified opinion leaders at 20 experimental hospitals who influenced peers through small and large group discussions, informal consultations, and revisions of protocols and clinical pathways. They focused on (1) evidence (drug efficacy), (2) comparative performance, and (3) barriers to change. Control hospitals received mailed performance feedback. Main Outcome Measures.-Hospital- specific changes before and after the intervention in the proportion of eligible patients receiving each study drug. Results.-Among experimental hospitals, the median change in the proportion of eligible elderly patients receiving aspirin was +0.13 (17% increase from 0.77 at baseline), compared with a change of -0.03 at control hospitals (P=.04). For β-blockers, the respective changes were +0.31 (63% increase from 0.49 at baseline) vs +0.18 (30% increase from baseline) for controls (P=.02). Lidocaine use declined by about 50% in both groups. The intervention did not increase thrombolysis in the elderly (from 0.73 at baseline), but nearly two thirds of eligible nonrecipients were older than 85 years, had severe comorbidities, or presented after at least 6 hours. Conclusions.-Working with opinion leaders and providing performance feedback can accelerate adoption of some beneficial AMI therapies (eg, aspirin, β-blockers). Secular changes in knowledge and hospital protocols may extinguish outdated practices (eg, prophylactic lidocaine). However, it is more difficult to increase use of effective but riskier treatments (eg, thrombolysis) for frail elderly patients.

AB - Context.-The effectiveness of recruiting local medical opinion leaders to improve quality of care is poorly understood. Objective.-To evaluate a guideline-implementation intervention of clinician education by local opinion leaders and performance feedback to (1) increase use of lifesaving drugs (aspirin and thrombolytics in eligible elderly patients, β-blockers in all eligible patients) for acute myocardial infarction (AMI), and (2) decrease use of a potentially harmful therapy (prophylactic lidocaine). Design.- Randomized controlled trial with hospital as the unit of randomization, intervention, and analysis. Setting.-Thirty-seven community hospitals in Minnesota. Patients.-All patients with AMI admitted to study hospitals over 10 months before (1992-1993, N=2409) or after (1995-1996, N=2938) the intervention. Intervention.-Using a validated survey, we identified opinion leaders at 20 experimental hospitals who influenced peers through small and large group discussions, informal consultations, and revisions of protocols and clinical pathways. They focused on (1) evidence (drug efficacy), (2) comparative performance, and (3) barriers to change. Control hospitals received mailed performance feedback. Main Outcome Measures.-Hospital- specific changes before and after the intervention in the proportion of eligible patients receiving each study drug. Results.-Among experimental hospitals, the median change in the proportion of eligible elderly patients receiving aspirin was +0.13 (17% increase from 0.77 at baseline), compared with a change of -0.03 at control hospitals (P=.04). For β-blockers, the respective changes were +0.31 (63% increase from 0.49 at baseline) vs +0.18 (30% increase from baseline) for controls (P=.02). Lidocaine use declined by about 50% in both groups. The intervention did not increase thrombolysis in the elderly (from 0.73 at baseline), but nearly two thirds of eligible nonrecipients were older than 85 years, had severe comorbidities, or presented after at least 6 hours. Conclusions.-Working with opinion leaders and providing performance feedback can accelerate adoption of some beneficial AMI therapies (eg, aspirin, β-blockers). Secular changes in knowledge and hospital protocols may extinguish outdated practices (eg, prophylactic lidocaine). However, it is more difficult to increase use of effective but riskier treatments (eg, thrombolysis) for frail elderly patients.

UR - http://www.scopus.com/inward/record.url?scp=0032490156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032490156&partnerID=8YFLogxK

U2 - 10.1001/jama.279.17.1358

DO - 10.1001/jama.279.17.1358

M3 - Article

VL - 279

SP - 1358

EP - 1363

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 17

ER -